High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome
- PMID: 12947028
- DOI: 10.1164/rccm.200306-766OC
High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome
Abstract
The treatment of atypical pneumonia, subsequently termed severe acute respiratory syndrome (SARS), is controversial, and the efficacy of corticosteroid therapy is unknown. We have evaluated the clinical and radiographic outcomes of 72 patients with probable SARS (median age 37 years, 30 M), who received ribavirin and different steroid regimens in two regional hospitals. Chest radiographs were scored according to the percentage of lung field involved. Seventeen patients initially received pulse steroid (PS) (methylprednisolone > or =500 mg/day) and 55 patients initially received nonpulse steroid (NPS) (methylprednisolone <500 mg/day) therapy. The cumulative steroid dosage; intensive care unit admission, mechanical ventilation, and mortality rates; and hematologic and biochemical parameters were similar in both groups after 21 days. However, patients in the PS group had less oxygen requirement, better radiographic outcome, and less likelihood of requiring rescue PS therapy than their counterparts. There was no significant difference between the two groups in hemolytic anemia, severe secondary infections, or hematemesis, but patients in the PS group had less hyperglycaemia. Initial use of pulse methylprednisolone therapy appears to be a more efficacious and an equally safe steroid regimen when compared with regimens with lower dosage and should be considered as the preferred steroid regimen in the treatment of SARS, pending data from future randomized controlled trials.
Comment in
-
Corticosteroids: the "terminator" of all untreatable serious pulmonary illness.Am J Respir Crit Care Med. 2003 Dec 15;168(12):1409-10. doi: 10.1164/rccm.2310004. Am J Respir Crit Care Med. 2003. PMID: 14668251 No abstract available.
Similar articles
-
Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.Respirology. 2004 Jun;9(2):173-83. doi: 10.1111/j.1440-1843.2004.00588.x. Respirology. 2004. PMID: 15182266 Free PMC article.
-
SARS: pharmacotherapy.Respirology. 2003 Nov;8 Suppl:S25-30. doi: 10.1046/j.1440-1843.2003.00525.x. Respirology. 2003. PMID: 15018130 Review.
-
Severe acute respiratory syndrome: clinical outcome and prognostic correlates.Emerg Infect Dis. 2003 Sep;9(9):1064-9. doi: 10.3201/eid0909.030362. Emerg Infect Dis. 2003. PMID: 14519241 Free PMC article.
-
[Evaluation of the efficacy and safety of corticosteroid in the treatment of severe SARS in Guangdong province with multi-factor regression analysis].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Feb;20(2):84-7. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008. PMID: 18279590 Chinese.
-
High-dose intravenous corticosteroid pulse therapy in alopecia areata: own experience compared with the literature.J Dtsch Dermatol Ges. 2008 May;6(5):375-8. doi: 10.1111/j.1610-0387.2007.06608.x. Epub 2008 Jan 17. J Dtsch Dermatol Ges. 2008. PMID: 18205838 Review. English, German.
Cited by
-
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic.Hemasphere. 2020 Jul 30;4(4):e432. doi: 10.1097/HS9.0000000000000432. eCollection 2020 Aug. Hemasphere. 2020. PMID: 32803132 Free PMC article. Review.
-
A review of treatment modalities for Middle East Respiratory Syndrome.J Antimicrob Chemother. 2016 Dec;71(12):3340-3350. doi: 10.1093/jac/dkw338. Epub 2016 Sep 1. J Antimicrob Chemother. 2016. PMID: 27585965 Free PMC article. Review.
-
Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic.Drug Des Devel Ther. 2021 Mar 4;15:983-995. doi: 10.2147/DDDT.S298691. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33692615 Free PMC article. Review.
-
Treatment and vaccines for severe acute respiratory syndrome.Lancet Infect Dis. 2005 Mar;5(3):147-55. doi: 10.1016/S1473-3099(05)01307-1. Lancet Infect Dis. 2005. PMID: 15766649 Free PMC article. Review.
-
Medical treatment of viral pneumonia including SARS in immunocompetent adult.J Infect. 2004 Nov;49(4):262-73. doi: 10.1016/j.jinf.2004.07.010. J Infect. 2004. PMID: 15474623 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous